Valuation: InfuSystem Holdings, Inc.

Market Cap 244M 212M 200M 182M 340M 23.43B 342M 2.39B 923M 11.88B 917M 897M 37.87B P/E 2026 *
28.7x
P/E 2027 * 21.6x
Enterprise Value 244M 212M 200M 182M 340M 23.43B 342M 2.39B 923M 11.88B 917M 897M 37.87B EV / Sales 2026 *
1.68x
EV / Sales 2027 * 1.58x
Free-Float
92.76%
Yield 2026 *
-
Yield 2027 * -
1 day+2.41%
1 week+3.03%
Current month+3.46%
1 month+3.37%
3 months+42.84%
6 months+31.35%
Current year+40.13%
1 week 11.8
Extreme 11.7999
12.63
1 month 11.79
Extreme 11.79
12.63
Current year 7.29
Extreme 7.29
12.97
1 year 7.29
Extreme 7.29
12.97
3 years 4.61
Extreme 4.61
12.97
5 years 4.61
Extreme 4.61
19.14
10 years 1.2
Extreme 1.2
23.26
Manager TitleAgeSince
Chief Executive Officer 49 2025-05-18
Director of Finance/CFO 55 2020-03-11
Chief Tech/Sci/R&D Officer 47 -
Director TitleAgeSince
Chairman 60 2018-12-18
Director/Board Member 64 2019-05-14
Director/Board Member 49 2021-03-17
Date Insider Type Main position Quantity % Market Cap. Importance
9/10/26
BlueLine Partners LLC
OthersCompany -20,000 0.1004%
9/10/26 Other

Director

0 0%
5/18/26 Exercice

Chief Executive Officer

21,379 0.1058%
Change 5-day change 1-year change 3-year change Capi.($)
+2.41%+3.03%+24.46%+25.70% 244M
+1.07%-1.95%-22.28%+2.16% 177B
-0.18%+1.57%-0.91%+12.72% 120B
-0.70%-0.82%+10.58%+79.12% 61.69B
-0.89%+2.45%-1.08%-30.38% 50.64B
+0.27%-4.01%+5.64%+33.91% 48.16B
+1.61%+5.07%+15.13%-7.52% 32.62B
+4.75%-0.76% - - 28.17B
+0.02%+7.69%+40.45%-8.05% 25.69B
+0.07%-3.55%-13.38%+1.93% 21.33B
Average +0.84%-1.08%+6.51%+12.18% 56.5B
Weighted average by Cap. +0.50%-1.25%-3.58%+12.07%

Financials

2026 *2027 *
Net sales 145M 126M 119M 108M 202M 13.93B 204M 1.42B 548M 7.06B 545M 533M 22.51B 154M 134M 126M 115M 215M 14.78B 216M 1.51B 582M 7.5B 579M 566M 23.9B
Net income 9.68M 8.39M 7.93M 7.2M 13.49M 929M 13.58M 94.68M 36.59M 471M 36.37M 35.57M 1.5B 11.82M 10.24M 9.68M 8.79M 16.47M 1.13B 16.57M 116M 44.66M 575M 44.4M 43.42M 1.83B
Net Debt - -
Logo InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. is a national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. Its segments include Patient Services and Device Solutions. Its core service within its Patient Services segment is its Oncology Business. Patient Services supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its Device Solutions segment’s core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment, sell treatment-related consumables, and provide biomedical recertification, maintenance and repair services for oncology practices and other healthcare site settings, including, home care and home infusion providers and others.
Employees
467
Date Price Change Volume
26-09-16 US$12.58 +2.57% 114,471
26-09-15 US$12.26 +0.08% 82,810
26-09-14 US$12.25 +0.82% 108,275
26-09-11 US$12.15 +0.25% 137,047
26-09-10 US$12.12 -0.66% 146,413
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
12.26USD
Average target price
16.83USD
Spread / Average Target
+37.30%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INFU Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!